pyrazinamide
Commercial- Indications
- Tuberculosis
Company intelligence / Profile preview
Calyx Chemicals & Pharmaceuticals has a four-decade track record as a leading Indian manufacturer of active pharmaceutical ingredients and intermediates. The company’s facilities are US FDA-inspected and have approvals from EDQM and WHO Geneva. It specializes in anti-tuberculars and anti-malarials with global regulatory compliance. Its products are commercialized worldwide; no clinical trial results apply as it does not develop finished drugs.
2 more assets in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Calyx Chemicals & Pharmaceuticals.